The Patent Finder

Statens Serum Institut

Also on record
Records under this name other than the patents Statens Serum Institut holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.

Back to Statens Serum Institut

PatentTitleStatus Expires Confidence
US 8,753,875Compositions and means for diagnosing microbial infections
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,749,507Malaria vaccine
Term ended
Term ended May 8, 2026 · From the USPTO record
Term endedTerm ended May 8, 2026From the USPTO record
US 11,278,581Use of Vaginal Lactobacilli for Improving the Success Rate of in Vitro Fertilization
Lapsed on the fee record
Ended Mar 22, 2026 · High confidence
Lapsed on the fee recordEnded Mar 22, 2026High confidence
US 8,277,823Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
Term ended
Term ended Aug 21, 2025 · From the USPTO record
Term endedTerm ended Aug 21, 2025From the USPTO record
US 8,293,250Tuberculosis vaccines comprising antigens expressed during the latent infection phase
Lapsed on the fee record
Ended Oct 23, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 23, 2024From the USPTO record
US 7,838,013Specific epitope based immunological diagnosis of tuberculosis
Term ended
Term ended Oct 3, 2024 · From the USPTO record
Term endedTerm ended Oct 3, 2024From the USPTO record
US 8,241,610Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines
Term ended
Term ended Jul 7, 2024 · From the USPTO record
Term endedTerm ended Jul 7, 2024From the USPTO record
US 8,114,609ADAM12, a novel marker for abnormal cell function
Lapsed on the fee record
Ended Feb 14, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 14, 2024From the USPTO record
US 8,101,193Tuberculosis vaccines comprising antigens expressed during the latent infection phase
Lapsed on the fee record
Ended Jan 24, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 24, 2024From the USPTO record
US 7,838,018Adjuvant combinations for immunization composition and vaccines
Term ended
Term ended Jan 4, 2024 · From the USPTO record
Term endedTerm ended Jan 4, 2024From the USPTO record
10 of 44 patents shown.
Pro members see all 44.
Pro members: see all 44 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited